Pharma-Bio Serv (PBSV) to Release Earnings on Monday

Pharma-Bio Serv (OTCMKTS:PBSV) is expected to announce its earnings results on Monday, January 27th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $4,000.00 billion for the quarter.

Pharma-Bio Serv Price Performance

Shares of PBSV opened at $0.58 on Friday. Pharma-Bio Serv has a one year low of $0.31 and a one year high of $1.08. The business has a fifty day moving average of $0.53 and a 200 day moving average of $0.58. The firm has a market capitalization of $13.34 million, a P/E ratio of -19.37 and a beta of 0.51.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.